California Innovation Fund

California Innovation Fund investment thesis

Funds California Innovation Fund I - Launched in 2021, the fund has made investments in 27 companies within the University of California ecosystem. The majority of investments are in Seed and Series A rounds, however it has taken advantage of its opportunistic mandate to invest in select later stage companies, notably leveraging its guaranteed pro rata rights access to oversubscribed rounds. The fund’s greatest industry exposure is to biotech and data/AI. California Innovation Opportunity Fund - Launching in 2026, Fund II seeks to replicate and expand on the success of Fund I. It will remain opportunistic on both company stage and sector, and will expand its deal flow pipeline to include additional robust university entrepreneurship ecosystems with ties to UC Berkeley and members of our te

California Innovation Fund team (8)

Partners and principals at California Innovation Fund:

• Jerry Bellman — sweet spot $1.5M
• Roger Benson — sweet spot $1.5M
• Kurt Beyer — sweet spot $1.5M
• Mateo Bueno — sweet spot $1.5M
• Liz Feinstein — sweet spot $1.5M
• Ashley Gould — sweet spot $1.5M
• Vanessa Kahkesh — sweet spot $1.5M
• Stacey King — sweet spot $1.5M

California Innovation Fund portfolio companies

Companies listed on California Innovation Fund's public materials include: Skip to Content, About, Team, Portfolio, Blog, Work With Us, Your360 AI, Prosper Medical, Stylus Medicine, Modelwise, TransCrypts, Vivere Oncotherapies, Cooler Heads, GC AI, LILT, Space Kinetic, Blings.io, Miist Therapeutics, Mammoth Biosciences, Eko Health, AnswersAi, Resemble AI, Encellin, EdVisorly, Synvivia, Selva Therapeutics, Calyx, SixMap, Engage Bio, Kyte, FreeWire Technologies, Catena Bioscience, Windfall, Sequin, Vision, Entrepreneurs, Partners, Site Credits, Photography.

Is California Innovation Fund a fit for your round?

Upload your pitch deck and see whether anyone at California Innovation Fund appears in your top matches.